title: Lack of evidence for prolonged double-long terminal repeat episomal HIV DNA stability in vivo.
authors.forename: Houria Hendel
authors.initials: HH
authors.lastname: Chavez
authors.forename: Tu-Anh
authors.initials: TA
authors.lastname: Tran
authors.forename: Bamory
authors.initials: B
authors.lastname: Dembele
authors.forename: Nadine
authors.initials: N
authors.lastname: Nasreddine
authors.forename: Olivier
authors.initials: O
authors.lastname: Lambotte
authors.forename: Brigitte
authors.initials: B
authors.lastname: Gubler
authors.forename: Emilie
authors.initials: E
authors.lastname: le Névot
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Delfraissy
authors.forename: Yassine
authors.initials: Y
authors.lastname: Taoufik
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D004279:DNA, Viral / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D010957:Plasmids / Q000235:genetics*; D012367:RNA, Viral; D014779:Virus Replication
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D012367:RNA, Viral